Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 20: 1438-1440, 1974;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lamon, J.
Right arrow Articles by Redeker, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lamon, J.
Right arrow Articles by Redeker, A. G.

Clinical Chemistry, Vol 20, 1438-1440, Copyright © 1974 by the American Association for Clinical Chemistry

The Hoesch Test: Bedside Screening for Urinary Porphobilinogen in Patients with Suspected Porphyria

Joel Lamon 1, Torben K. With 1, and Allan G. Redeker 1

1 Department of Internal Medicine, University of Southern California School of Medicine, Los Angeles, Calif. 90033; and the Department of Chemical Pathology, Svendborg Hospital, 5700 Svendborg, Denmark.

A little-known procedure for porphobilinogen screening, the Hoesch test, was examined for sensitivity, specificity, and utility as compared to the Watson-Schwartz test. The data demonstrate that its sensitivity is similar to that of the Watson-Schwartz test. The Hoesch test, however, is without false-positive reactions secondary to urobilinogen, and its simplicity makes it easier to use and more easily interpretable. We conclude that the Hoesch test should replace the Watson-Schwartz test for urine porphobilinogen screening in suspected cases of acute intermittent and variegate porphyria.


Key Words: Watson-Schwartz • "reversed Ehrlich reaction" • screening

Submitted on June 28, 1974
Accepted on August 26, 1974




The following articles in journals at HighWire Press have cited this article:


Home page
 ANN INTERN MEDHome page
K. E. Anderson, J. R. Bloomer, H. L. Bonkovsky, J. P. Kushner, C. A. Pierach, N. R. Pimstone, and R. J. Desnick
Recommendations for the Diagnosis and Treatment of the Acute Porphyrias
Ann Intern Med, March 15, 2005; 142(6): 439 - 450.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. E. Ford, M. J. Magera, K. M. Kloke, P. A. Chezick, A. Fauq, and J. P. McConnell
Quantitative Measurement of Porphobilinogen in Urine by Stable-Isotope Dilution Liquid Chromatography-Tandem Mass Spectrometry
Clin. Chem., September 1, 2001; 47(9): 1627 - 1632.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1974 by the American Association for Clinical Chemistry.